Stockreport

Innovus Pharma Reports Quarterly Revenue for the First Quarter 2019 of $5.4 Million, a 18.0% Increase from Comparable Quarter in the Prior Year

InnovAge Holding Corp.  (INNV) 
NASDAQ:AMEX Investor Relations: innovuspharma.com
PDF Cash, inclusive of merchant processor holdback, of $2.9 million as of May 13, 2019 SAN DIEGO--(BUSINESS WIRE)-- Innovus Pharmaceuticals, Inc. [Read more]